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Abstract Since bioprosthetic valve dysfunction may
arise due to histological calcification in the crosslinking
process by glutaraldehyde (GA), non-GA crosslinking
reagents have been investigated. We compared the efficacy
of triglycidylamine (TGA), a newly synthesized epoxy
compound, and GA as crosslinking reagents for the treat-
ment of autologous tissues. We assessed the strength of
crosslinked tissues using shrinkage temperature (Ts) mea-
sured by differential scanning calorimetry. We also con-
ducted subdermal allografting of the crosslinked
pericardium and thoracic aorta in rats, and verified the anti-
calcification efficacy of TGA by histological evaluations
with von Kossa stain, and immunological evaluations using
tenascin-C (TN-C) or matrix metalloproteinase-9 (MMP-
9). TGA treatment resulted in slower increases in Ts of the
pericardium, and it required 9–12 h to reach Ts achieved
by GA. In subdermal implantation of rat tissues, calcium
content was lower in the TGA group than in the GA groups
(p \ 0.005). The expression site of TN-C and MMP-9
differed from the primary location of calcium deposition in
the thoracic aorta treated with TGA suggesting a different
underlying mechanism in calcification between GA and
TGA crosslinking. In conclusion, TGA crosslinking in the
allograft showed superior anti-calcification effect as com-
pared to brief treatment by GA, although TGA crosslinking
process was slow.
Keywords Triglycidylamine  Glutaraldehyde 
Crosslinking  Shrinkage temperature  Calcification
Introduction
Glutaraldehyde (GA) has been widely used in the cross-
linking treatment of heterograft bioprosthetic valves for the
past 40 years [1, 2]. The GA crosslinking eliminates anti-
genicity and provides tensile strength and pliability.
However, structural bioprosthetic valve deterioration may
arise mostly due to histological calcification caused by the
residue of unstable GA and phospholipids which react with
the devitalized connective tissue cells even in an advanced
GA fixation method that takes several days [3, 4]. A short
time fixation of autologous pericardium on operation site is
also a common practice in cardiovascular reconstruction.
Such brief GA fixation, however, may cause functional
disturbance due to serious calcification and loss of elas-
ticity in the long term. Nonetheless, until now no well-
defined guidelines for the on-site brief GA fixation have yet
been established, and information regarding tissue strength,
calcium contents and histological features of briefly treated
tissues has been limited. Thus, an important purpose of this
study is a search for a novel crosslinking agent that is
superior to GA even in on-site brief crosslinking.
Epoxy compounds have been widely used as crosslink-
ing agents, adhesion promoters, and stabilizers of textile
and paper [5, 6]. Triglycidylamine (TGA; C9H15NO3, MW
185.22) is a newly synthesized epoxy compound which has
a large number of effective epoxy functional groups, and is
thus expected to exhibit high reactivity (Fig. 1). A previous
study reported increased calcification resistance in sub-
dermal implants in a study using porcine aortic valve and
bovine pericardium [7]. TGA-treated pericardium
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demonstrated stable mechanical function in a mitral val-
vuloplasty model [8].
In this study, we aimed to explore the efficacy of TGA
as a novel crosslinking reagent. We assessed the strength of
crosslinked tissues using shrinkage temperature (Ts) mea-
sured by differential scanning calorimetry (DSC). We also
conducted subcutaneous allografting of the crosslinked
pericardium and thoracic aorta in rats, and verified the
efficacy of TGA in terms of anti-calcification effect.
Shrinkage temperature and anti-calcification property of
TGA-crosslinked autologous tissues were compared with
those of tissues treated by GA for a short period
(10–30 min).
Materials and methods
TGA synthesis
TGA was synthesized as previously described [7]. In brief,
aqueous ammonia was reacted with an excess of epichlo-
rohydrin and catalytic amounts of ammonium triflate in
isopropanol. The solvents were distilled off and the resid-
ual epichlorohydrin was removed. The resulting syrup
consisting mostly of tris-(3-chloro-2-hydroxypropyl) amine
was dissolved in a mixture of toluene, tetrahydrofuran and
tert-butanol. An excess of 50 % aqueous NaOH solution
was added. In 2 h, the epoxy ring closure was complete. Ice
cold water was added to dissolve the precipitate of NaCl.
The desiccant was filtered and vacuum-concentrated. The
residue was vacuum-distilled to give pure TGA. A novel
cold crystallization technique resulted in a coarse white
water-soluble powder, preserved in dark place at room
temperature.
Tissue preparation and crosslinking
We obtained the remnant of fresh human pericardium
which was harvested during surgery with the approval of
our institutional ethics committee on human research
(approval number H22-612). Written informed consent was
obtained from each patient. Pericardium was rinsed in
saline, then divided into 4 portions and fixed with GA and
TGA as follows. We divided the samples into two groups
to determine whether GA plays a role directly in the tissue
calcification process: the GA group (0.6 % GA; diluted
8 % GA with distilled water) and the GA-c group (0.6 %
GA following Carpentier’s recipe; 8 % GA 26 mL, dis-
tilled water 700 mL, MgCl2 4 g, and 1 M HEPES 20 mL,
pH 7.4) [3, 4]. In both GA-fixed groups, pericardium was
treated at room temperature for 10, 20 or 30 min. Tissues
fixed with TGA were treated with 100 mmol/L TGA in
borate mannitol buffer (25 mmol/L sodium tetraborate
decahydrate, pH 7.4) at 37 C, for 1, 3, 6, 9, or 12 h.
DSC analysis
The temperature at which denaturation and shrinkage under
constant load begins is termed ‘‘shrinkage temperature’’, an
indicator of collagen crosslinking density and tissue
strength [1, 7, 9]. DSC is a thermo-analytical technique in
which the difference in the amount of heat required to
increase the temperature of a sample and a reference
material (aluminum) is measured. When a solid sample
melts, more heat energy is absorbed as compared to the
reference material as a heat of fusion. In crystallization,
heat is released as the exothermic reaction. By observing
the difference in heat flow between the sample and refer-
ence material, DSC is able to measure the amount of heat
absorbed or released during phase transitions [9]. In a DSC
analyzer (X-DSC700, Seiko Instruments Inc., Japan), tissue
samples (approximately 4–5 mg) were sealed in aluminum
pans and heated at a rate of 10 C/min from 40 to 100 C,
and then Ts was determined as the temperature measured at
the endothermic peak.
Rat subdermal implants and tissue calcification
measurement
The Committee on Animal Research at the University of
Tsukuba approved the experimental protocols. The rats
used were cared for according to the Guiding Principles
based on the Helsinki Declaration. Male Wister rats were
used (n = 45). The number of donor rat was 36 and reci-
pient was nine. A piece of pericardium and thoracic aorta
was excised from one donor rat. Total number of 36 pieces
of pericardium and thoracic aorta were divided into four
groups: GA, GA-c, TGA and untreated control (n = 9,
each). One recipient rat accepted four pieces of pericar-
dium and thoracic aorta from four different donors.
Materials were fixed at room temperature for 10 min in the
GA and GA-c groups, and at 37 C for 12 h in the TGA
Fig. 1 A chemical structure of GA (a) and TGA (b). Whereas GA
has a rigid and hydrophobic five-carbon chain, TGA has a flexible
ether bond
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group. All materials and untreated control materials were
implanted subdermally. After 21 days, on animal killing,
all materials were removed and rinsed in saline. Each
material (15–40 mg dry weight) was hydrolyzed in 1 mL
of 6 N HCl at 70 C for 4–6 h. The solution was filtered
and diluted with distilled water in 0.01 N HCl. The calcium
content of each material was measured based on the aliquot
concentration of each hydrolysate using an inductively
coupled plasma atomic emission spectrometry method
(ICP-AES) by a spectrometer (ICP-8100, Shimazu, Japan).
ICP-AES is a type of emission spectroscopy that uses
inductively coupled plasma to produce excited atoms and
ions [10].
Histological processing of explants
Rat subdermal explants embedded in paraffin were cut to
5 lm cross sections and stained with von Kossa stain.
Serial sections were also immunostained using peroxidase
methodology for either tenascin-C (TN-C) or matrix
metalloproteinase (MMP)-9, using human TN-C mono-
clonal antibody (Cosmo Bio, Japan) and rabbit anti-MMP-
9 monoclonal antibody (Abcam, Japan). Universal
immuno-peroxidase polymer for rat (Nichirei, Japan) was
used as secondary antibodies and peroxidase complex. The
immune complexes were colored using diaminobenzidine
solution (Simple Stain DAB solution, Nichirei, Japan).
Staining of von Kossa was scored visually, with a
numerical rating of 1–5 assigned based on the following
criteria: 1 = negative, 2 = rare detection, 3 = sparse but
consistent, 4 = uniformly present, and 5 = intense and
wide-spread staining.
Data analyses
Quantitative results were expressed as mean ± standard
error of the mean. Differences between each group were
assessed using unpaired Student’s t test. Data were termed
significant when p \ 0.05.
Results
Ts measurements by DSC analysis
The DSC results showed that brief treatment with GA
increased the Ts of the pericardium, indicating GA’s ability
to rapidly crosslink the tissue. There was no significant
difference in the Ts of pericardium between GA and GA-c
groups for any treatment period. For TGA treatment,
increases in the Ts of the pericardium were slow in com-
parison with those observed in the GA-crosslinked tissues;
it took 9–12 h of reaction time to reach the equal level of
Ts achieved by GA crosslinking (Fig. 2).
Rat subdermal implants and tissue calcification
measurement
There were no significant differences between the GA and
GA-c groups in the calcium content (lg/mg, on a dry tissue
weight basis) of the pericardium (11.0 ± 2.4 vs. 12.9 ± 1.3,
p = 0.52) or thoracic aorta (16.6 ± 2.1 vs. 12.7 ± 1.3,
p = 0.14). Calcium content was significantly lower in the
Fig. 2 Crosslinking strength of GA, GA-c and TGA groups.
Shrinkage temperature (Ts) of human pericardium. 9–12 h of 37 C
treatment with TGA results in Ts equal to that of the GA and GA-c
groups’ 10 min-treatment at room temperature
Fig. 3 Calcium content of 21-day rat subdermal explants, showing
reduced calcification in both homologous pericardium and thoracic
aorta treated with TGA as compared to GA or GA-c group.
*P \ 0.005 vs. TGA, **P \ 0.001 vs. TGA-P: pericardium, -TA:
thoracic aorta
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TGA group than in both the GA and GA-c groups: the cal-
cium content of the pericardium was 1.0 ± 0.5 (p = 0.0036
vs. GA group, and p = 0.00036 vs. GA-c group), and that of
the thoracic aorta was 5.6 ± 0.4 (p = 0.0013 vs. GA group,
and p = 0.0011 vs. GA-c group) (Fig. 3).
Histological processing of explants
Staining of von Kossa showed strong calcium deposition in
the GA group from the tunica media to the adventitia, but
not in the intima. In the TGA group, on the other hand, the
degree of calcification was mild and the deposition was
uniform from the tunica intima to the adventitia, although
the accumulation was a little higher close to the adventitia.
Moreover, in the GA group, strong calcification was noted
in the smooth muscle layer, and some of the samples did
not exhibit calcium deposition in the elastic lamina layers.
Calcification observed in the TGA group was higher in the
fenestrated elastic laminae than in the smooth muscle layer.
Quantitatively, the overall calcium deposition in the peri-
cardium was scored as 2.3 ± 0.3 in the GA group
(p = 0.00011, vs. TGA), 1.4 ± 0.1 in the GA-c group
(p = 0.0091, vs. TGA), and 1.0 ± 0.1 (nearly negative) in
the TGA group, and that in the thoracic aorta was scored as
4.0 ± 0.1 in the GA group (p = 0.00023, vs. TGA),
4.0 ± 0.1 in the GA-c group (p = 0.00026, vs. TGA), and
2.4 ± 0.1 in the TGA group. Thus, the degree of calcifi-
cation was significantly lower in the TGA-treated tissues
compared with GA (Figs. 4, 5).
Immunohistochemical staining revealed that TN-C and
MMP-9 were similarly expressed in the samples treated with
GA and TGA. In the pericardium, both proteins were
expressed diffusely along the pericardial tissue, and in the
thoracic aorta they were strongly expressed in the cellular
components located between fenestrated elastic laminae,
especially in the layer rich in smooth muscle cells. The
expression patterns of TN-C and MMP-9 were almost con-
sistent with the calcification distribution in the pericardium
and thoracic aorta in the GA and GA-c groups. In the TGA
group, however, despite the similar expression of TN-C and
MMP-9, calcification of the pericardium was significantly
mild. Moreover, the expression site of TN-C and MMP-9
(mainly in the smooth muscle layer) differed from the pri-
mary location of calcium distribution (fenestrated elastic
laminae) in the thoracic aorta treated with TGA (Figs. 4, 5).
Discussion
In efforts to prevent calcification of GA-treated biopros-
thetic valves, Carpentier et al. reported that a 6-day-long
thermal fixation decreases unstable GA and phospholipids
Fig. 4 Histochemistry of
pericardium; von Kossa staining
and immunohistochemistry of
GA group (a, b, c), GA-c group
(d, e, f) and TGA group (g, h, i).
von Kossa staining of 21-day
pericardium explants showing
significant calcification (black
arrow) in GA and GA-c groups
(a, d), in contrast an absence of
calcified staining in TGA group
(g). Immunohistochemistry for
TN-C and MMP-9 demonstrated
lower expression in TGA group
(white arrow). Magnification:
9400 (a–i)
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inside bovine pericardium, and therefore inhibits calcifi-
cation with better elasticity [3, 4]. An additional treatment
with ethanol, which was reported by Vyavahare et al. [1],
has also been in practical use. These treatments have been
effective in enhancing the durability of bioprostheses;
however, even with such a long time fixation, complete
inhibition of calcification has not yet been achieved.
Brief fixation of autologous pericardium for about
3–10 min at low GA concentrations on surgical site is also
a common practice. This quick GA crosslinking without
thermal fixation, however, may cause not only functional
disturbances due to serious calcification, but also hardening
of autologous pericardium and loss of elasticity in the long
term. In addition, because of the hydrophobicity and per-
sistent toxicity of unstable GA, host cells do not infiltrate
the implanted tissue, resulting in decreased biocompati-
bility [5]. Nonetheless, on-site fixation of pericardium is
still indispensable for various surgical procedures and the
fixation needs to be completed within no more than 30 min
otherwise it prolongs operation time unnecessarily.
The possible use of epoxy compounds as crosslinking
agents for bioprostheses has been studied, and the com-
pounds with high water solubility have been the focus [6,
11]. Whereas GA has a rigid and hydrophobic five-carbon
chain which makes GA-treated bioprostheses less pliable
and hydrophobic, epoxy compounds have a flexible ether
bond in each molecule and therefore epoxy compound-
treated tissues are considered to maintain better pliability
(Fig. 1). Epoxy compounds form crosslinks with amino,
carboxyl, and hydroxyl groups, and create hydroxyl group-
bearing molecules after the reaction, making the products
more hydrophilic (Fig. 6). Also, TGA crosslinking has
been demonstrated to result in a change in collagen struc-
ture that could interfere with collagenase-substrate inter-
actions. Moreover, epoxy crosslinking is considered to
involve reactions with sulfur-containing amino acids
besides common amino acid groups such as the lysine
amino side chain in collagen. These connective tissue
matrices generated from TGA-amino acid reactions have a
complex and firm structure involving collagen–collagen
and collagen-protein bonds [7].
TGA is an epoxy compound originally synthesized by
Connolly et al. [7] in crosslinking experiments. They
reported superior anti-calcification effects, maintenance of
pliability, and favorable mechanical hemodynamics. Our
DSC results, however, showed that increases in the Ts of
the pericardium were markedly slow in the TGA group. It
took 9–12 h to attain equivalent levels of strength to brief
GA treatment. Since crosslinking reactions of epoxy
compounds begin with an epoxy ring opening and such
ring-opening reactions are slow processes, this may explain
why TGA treatment required the longer reaction time than
Fig. 5 Histochemistry of
thoracic aorta; von Kossa
staining and
Immunohistochemistry of GA
group (a, b, c), GA-c group (d,
e, f) and TGA group (g, h, i).
von Kossa staining of 21-day
thoracic aorta explants showing
less calcified tissue in TGA
group (g) compared to GA and
GA-c groups (a, d) (black
arrow). Calcium deposition was
observed in the layer containing
smooth muscle cells separated
by fenestrated elastic laminae
(white arrow head) in GA and
GA-c groups, while in the layer
corresponding to fenestrated
elastic laminae (white arrow
head) in TGA group.
Immunohistochemistry for TN-
C and MMP-9 demonstrated
lower expression in TGA group
(white arrow). Magnification:
9400 (a–i)
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that of GA crosslinking. This issue is a major flaw of TGA
crosslinking process and therefore increasing the reaction
rate in TGA treatment would be one major goal to enhance
the clinical relevance of TGA crosslinking. Similar to other
epoxy compounds, it is recognized that reaction rate in
TGA treatment is accelerated by high temperature over
100 C (personal communication). However, considering
the denaturation of proteins, a reaction temperature range
between about 20 to 40 C should be appropriate for
crosslinking treatment of biological materials. In the
present experiment, we applied TGA only at a concentra-
tion of 100 mmol/L in accordance with the investigation by
Connolly and colleagues [12]. Using higher TGA concen-
trations may be another option to reduce the treatment time
and further investigations are needed. From another aspect
to accelerate the TGA reaction, tertiary amines and imi-
dazoles may be useful as catalysts for ring-opening reac-
tions [11]. While tertiary amines are highly cytotoxic and
inapplicable to bioprostheses, imidazole-containing com-
pounds are used as antifungal drugs in clinical settings and
therefore are likely to become a useful option.
Elastin is an extracellular matrix protein present in
various tissues, including arterial walls and heart valves.
Elastin calcification occurs in arteriosclerosis or valvular
heart disease other than structural bioprosthetic valve
deterioration [13]. The expression of the MMP family
proteins is known to be involved in elastin calcification.
MMPs are mainly produced by smooth muscle cells and
macrophages, and their activity is inhibited by tissue
inhibitors of metalloproteinases (TIMP). Various studies
have revealed that the histological calcification induced by
GA treatment is caused by an imbalance of MMP-9 and
TIMP, resulting in a significant increase in MMP-9 activity
that promotes elastin degradation, thereby increasing the
levels of elastin peptides. The elastin peptides stimulate
migration of fibroblasts, smooth muscle cells, and mono-
cytes, and these components activate MMP-9 in a positive
feedback [13]. It has been reported that TN-C is often co-
expressed with MMPs in a variety of tissues, and is
involved in the activation of cytokines and the promotion
of calcium binding. In addition, TN-C has been reported to
increase the expression of MMP family members [14].
There were no significant differences in Ts, the degree
of calcium deposition, and expression patterns of TN-C and
MMP-9 between the GA group and the GA-c group. In
both the GA and TGA crosslinking treatments, TN-C and
MMP-9 were observed in the smooth muscle layer of the
thoracic aortic media, indicating that the extracellular
matrix degenerating enzyme of the MMP family is pro-
duced in smooth muscle cells and extracellular matrix
glycoprotein TN-C is involved in the calcification process.
However, in the TGA-treated thoracic aorta, the expression
sites of TN-C and MMP-9 were not consistent with the
calcium deposition sites, whereas the expression sites of
both proteins well coincided with the calcium deposition
sites in the GA-treated aorta. The reason for this phe-
nomenon is unclear, but it may suggest the existence of a
different mechanism from the emergence of TN-C and
MMP-9 to calcium deposition between GA and TGA
crosslinking in the aortic wall. It is also unclear why the
degree of calcium deposition was different between the
pericardium and the thoracic aorta in the TGA treatment.
Whereas the aortic wall consists of smooth muscle cells,
fibroblasts and plasma cells in addition to elastin and
Fig. 6 Epoxy group forms
crosslinks with amino (-NH2),
carboxyl (-COOH), and
hydroxyl (-OH) groups of
collagen, and then creates
hydroxyl group-bearing
molecules, making the
crosslinked products more
hydrophilic. R denotes the
epoxy-bearing substances
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collagen, the pericardium mostly involves mesothelium,
collagen and elastin, and lacks smooth muscle layer which
is the main expression site of TN-C and MMP-9 in the
TGA-treated aorta. This fact may be a clue to solve a riddle
in the difference of calcium deposition between the two
different tissues. Difference in the histological background
may vary the expression or activity of TN-C and MMP-9,
or may produce different signal transmission between cells
in the activation of cytokines and further promotion of
calcium binding process.
There are several limitations. The most significant of
which concerns the usage of allograft in the rat tissue
implant experiments. In addition, it is a subdermal
implantation for only 21 days. Therefore, the present study
may not be clinically relevant and further chronic animal
studies which implant autograft need to be carried out.
Conclusions
TGA crosslinking showed superior anti-calcification effect
as compared to GA. The expression site of TN-C and
MMP-9 in the TGA group differed from the primary
location of calcium deposition. When the underlying
mechanism of such a TGA’s feature in calcification process
is elucidated, efficacy and clinical relevance of TGA as a
promising crosslinking agent may be more emphasized
even in brief on-site fixation.
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